[HTML][HTML] Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
… Experimental trial participants are not only an inherently poor … potential differences between
experimental and observational cohorts may contribute to poor replicability, we compared …
experimental and observational cohorts may contribute to poor replicability, we compared …
Feasibility of using real-world data to replicate clinical trial evidence
… electronic health records and other health care transaction systems as a potential source of
medical … In this study of US-based clinical trials with human participants that were published …
medical … In this study of US-based clinical trials with human participants that were published …
Baseline characteristics and risk profiles of participants in the ISCHEMIA randomized clinical trial
JS Hochman, HR Reynolds, S Bangalore… - JAMA …, 2019 - jamanetwork.com
… Of 6 potential responses, participants who chose “extremely … after enrollment and between
participants qualifying on the … , highlighting the differences between anatomic evidence of …
participants qualifying on the … , highlighting the differences between anatomic evidence of …
“When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials
JM Unger, DL Hershman, C Till… - JNCI: Journal of the …, 2021 - academic.oup.com
… were initially deemed eligible for trial participation. Further, … was used, using the mean of
the difference between study … the potential upper bound on the trial participation estimate, …
the difference between study … the potential upper bound on the trial participation estimate, …
[HTML][HTML] Digitizing clinical trials
… clinical trial enterprise, including the opportunity to run trials … A fully digital trial will enable
access for potential participants … difficulties 18 and overly restrictive eligibility criteria 19 . The …
access for potential participants … difficulties 18 and overly restrictive eligibility criteria 19 . The …
Association of patient comorbid conditions with cancer clinical trial participation
… opportunities for trial participation for several thousand patients with … potential improvements
in trial participation rates compared with removing all major comorbidity-related eligibility …
in trial participation rates compared with removing all major comorbidity-related eligibility …
Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial
…, M Martin, Y Yamamoto, C Partridge, E Moreira… - Bmj, 2021 - bmj.com
… and masking Eligible patients were identified using an acute … at the patient level, allowing
for providers potentially to learn … the research to individual study participants, but the results of …
for providers potentially to learn … the research to individual study participants, but the results of …
Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials
JL Kwan, L Lo, J Ferguson, H Goldberg… - Bmj, 2020 - bmj.com
… the potential for clinical effect—conferred by clinical decision … and studies in which fewer
than half of participants were … bias (systematic differences between groups with respect to the …
than half of participants were … bias (systematic differences between groups with respect to the …
Factors associated with age disparities among cancer clinical trial participants
… Across all trials, we observed a substantial difference between the median age of trial
participants and the population … A potential contributing factor could be that industry-funded …
participants and the population … A potential contributing factor could be that industry-funded …
Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial
…, M Shirinian, M Fung, T Overton, V Malhotra, E Kissin… - Jama, 2021 - jamanetwork.com
… Eligible participants were hospitalized patients with severe … Patients were not eligible if they
had been treated with therapies … to the potential rapid deterioration of patients’ clinical status …
had been treated with therapies … to the potential rapid deterioration of patients’ clinical status …